MEDIPOST Co., Ltd.
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2000-01-01
- Employees
- 290
- Market Cap
- -
- Website
- http://www.medi-post.co.kr
Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Biological: Pneumostem®Biological: normal saline
- First Posted Date
- 2013-07-12
- Last Posted Date
- 2020-08-07
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 62
- Registration Number
- NCT01897987
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Biological: Pneumostem®Other: Normal Saline
- First Posted Date
- 2013-04-11
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 69
- Registration Number
- NCT01828957
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects
- Conditions
- Degeneration Articular Cartilage Knee
- Interventions
- Biological: CARTISTEM®
- First Posted Date
- 2012-11-26
- Last Posted Date
- 2021-07-30
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT01733186
- Locations
- 🇺🇸
Cartilage Restoration Center; RUSH University Medical Center, Chicago, Illinois, United States
🇺🇸Cartilage Repair Center; Brigham and Women's Hospital, Chestnut Hill, Massachusetts, United States
Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect
- Conditions
- Defect of Articular CartilageDegenerative Osteoarthritis
- Interventions
- Procedure: MicrofractureBiological: CARTISTEM
- First Posted Date
- 2012-06-25
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 103
- Registration Number
- NCT01626677
- Locations
- 🇰🇷
Hanyang University Medical Center, Seoul, Korea, Republic of
🇰🇷Inha University Hospital, Incheon, Korea, Republic of
🇰🇷Kangbuk Samsung Hospital, Seoul, Korea, Republic of
Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Biological: Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
- First Posted Date
- 2011-02-16
- Last Posted Date
- 2014-04-07
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT01297205
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease
- Conditions
- Dementia of the Alzheimer's Type
- Interventions
- Biological: Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
- First Posted Date
- 2011-02-16
- Last Posted Date
- 2012-04-23
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT01297218
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury
- Conditions
- OsteoarthritisCartilage Injury
- Interventions
- Biological: CartistemProcedure: Microfracture treatment
- First Posted Date
- 2009-12-30
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 104
- Registration Number
- NCT01041001
- Locations
- 🇰🇷
Seoul Veterans Hospital, Seoul, Korea, Republic of
🇰🇷Inha University Hospital, Incheon, Korea, Republic of
🇰🇷Gachon University Gil Hospital, Incheon, Gyunggido, Korea, Republic of
Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation
- Conditions
- Acute Leukemia
- Interventions
- Biological: Human umbilical cord blood-derived mesenchymal stem cells
- First Posted Date
- 2009-01-15
- Last Posted Date
- 2012-04-23
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT00823316
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of